Overview

A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine

Status:
Recruiting

Trial end date:
2022-04-11

Target enrollment:

Participant gender:

Summary

The main objective of this trail is to investigate if and to what extent BI 409306, BI 425809 and lamotrigine attenuate ketamine induced cognitive deficits.

Phase:

Phase 1

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

BI 409306
BI 425809
Lamotrigine